RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,193 filers reported holding RAYTHEON CO in Q3 2017. The put-call ratio across all filers is 1.06 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $108,990,000 | -44.4% | 831,034 | -6.9% | 0.46% | -29.5% |
Q4 2019 | $196,093,000 | +82.5% | 892,386 | +63.0% | 0.65% | +55.5% |
Q3 2019 | $107,428,000 | +35.3% | 547,570 | +19.9% | 0.42% | +38.4% |
Q2 2019 | $79,388,000 | -3.4% | 456,570 | +1.2% | 0.30% | -7.4% |
Q1 2019 | $82,177,000 | +17.5% | 451,323 | -1.1% | 0.33% | +7.9% |
Q4 2018 | $69,954,000 | -27.9% | 456,175 | -2.9% | 0.30% | -16.6% |
Q3 2018 | $97,089,000 | +120.5% | 469,803 | +106.1% | 0.36% | +65.3% |
Q2 2018 | $44,026,000 | +2.1% | 227,900 | +14.0% | 0.22% | -5.2% |
Q1 2018 | $43,132,000 | -29.0% | 199,852 | -38.2% | 0.23% | -7.6% |
Q4 2017 | $60,753,000 | +40.0% | 323,412 | +39.0% | 0.25% | +30.9% |
Q3 2017 | $43,406,000 | – | 232,638 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |